ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma

- Jackson, Evangeline R., Duchatel, Ryan J., Le Grand, Marion, Kearney, Padraic S., Douglas, Alicia M., Findlay, Izac J., Germon, Zacary P., McEwen, Holly P., Beitaki, Tyrone S., Patabendige, Adjanie, Skerrett-Byrne, David A., Nixon, Brett, Staudt, Dilana E., Smith, Nathan D., Day, B, Manoharan, N, Nagabushan, S, Hansford, JR, Govender, D, McCowage, GB, Firestein, R, Howlett, M, Endersby, R, Persson, Mika L., Gottardo, NG, Alvaro, F, Waszak, SM, Larsen, MR, Colino-Sanguino, Y, Valdés-Mora, F, Rakotomalala, A, Meignan, S, Pasquier, E, Andre, N, Mannan, Abdul, Hulleman, E, Eisenstat, DD, Vitanza, NA, Nazarian, J, Koschmann, C, Mueller, S, Cain, JE, Dun, MD, Yadavilli, Sridevi, Parackal, Sarah, Game, Shaye, Chong, Wai Chin, Jayasekara, W. Samantha N.

Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma

- Messinger, Dana, Harris, Micah K., Qin, Tingting, Mullan, Brendan, Siada, Ruby, Ravindran, Ramya, Niculcea, Michael, Dowling, Abigail R., Bradin, Joshua, Ginn, Kevin F., Gener, Melissa A. H., Dorris, Kathleen, Cummings, Jessica R., Vitanza, Nicholas A., Schmidt, SV, Spitzer, J, Li, J, Filbin, MG, Cao, X, Castro, MG, Lowenstein, PR, Mody, R, Chinnaiyan, A, Thomas, Chase, Desprez, PY, McAllister, S, Dun, Matthew D., Hawkins, C, Waszak, SM, Venneti, S, Koschmann, C, Yadav, VN, Yang, Tao, Sweha, Stefan R., Woo, Rinette, Siddaway, Robert, Burkert, Martin, Stallard, Stefanie